Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Fuxing Biotechnology is a Chinese biotechnology company primarily focused on the research, development, and large-scale production of bioactive substances and pharmaceutical intermediates. The company is a major global manufacturer of reduced glutathione (GSH), utilizing advanced fermentation and purification technologies. Its product portfolio serves the pharmaceutical, nutraceutical, and cosmetic industries, with applications ranging from liver protection and detoxification to skin whitening. As a subsidiary of the publicly traded Hubei Fuxing Science and Technology Co., Ltd., the company maintains significant manufacturing infrastructure in Hubei Province to support international supply chains.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Fuxing Biotechnology.